Oxidant stress—a major cause of reduced endothelial nitric oxide availability in cardiovascular disease

Author： Landmesser Ulf   Harrison David   Drexler Helmut  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.62, Iss.1, 2006-02, pp. : 13-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Nitric oxide therapy For cardiovascular disease

By Laight David W  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 6, 2001-06 ,pp. : 999-1005

Informa Healthcare

Access to resources Recommend Favorite

Roles of Cardiovascular Risk Factors in Endothelial Nitric Oxide Synthase Regulation: An Update

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3563-3578

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Bradykinin in the Regulation of Endothelial Nitric Oxide Synthase Expression by Cardiovascular Drugs

By  

Current Pharmaceutical Design, Vol. 23, Iss. 40, 2018-02 ,pp. : 6215-6222

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial nitric oxide synthase gene: prospects for treatment of heart disease

By Cooke Glen E   Doshi Amit   Binkley Philip F  

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1723-1734

Future Medicine

Access to resources Recommend Favorite

Endothelial calcium-activated potassium channels as therapeutic targets to enhance availability of nitric oxide

By Kerr Paul M.   Tam Raymond   Narang Deepak   Potts Kyle   McMillan Dane   McMillan Kale   Plane Frances  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 6, 2012-06 ,pp. : 739-752

NRC Research Press

Access to resources Recommend Favorite